Ninety One (UK)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-547,985
Closed -$61.4M 210
2025
Q1
$61.4M Buy
+547,985
New +$56.5M 0.17% 86
2020
Q2
Sell
-97,422
Closed -$7.28M 241
2020
Q1
$7.28M Buy
+97,422
New +$6.73M 0.03% 182
2019
Q3
Sell
-4,995
Closed -$337K 251
2019
Q2
$337K Sell
4,995
-565
-10% -$37.2K ﹤0.01% 253
2019
Q1
$361K Buy
5,560
+931
+20% +$61.9K ﹤0.01% 259
2018
Q4
$290K Buy
+4,629
New +$324K ﹤0.01% 274
2018
Q2
Sell
-87,345
Closed -$6.58M 271
2018
Q1
$6.58M Sell
87,345
-110
-0.1% -$8.74K 0.04% 181
2017
Q4
$6.26M Sell
87,455
-3,838
-4% -$291K 0.03% 220
2017
Q3
$7.4M Sell
91,293
-3,014
-3% -$230K 0.03% 211
2017
Q2
$6.67M Buy
+94,307
New +$6.28M 0.03% 202
2017
Q1
Sell
-1,528,098
Closed -$109M 318
2016
Q4
$109M Sell
1,528,098
-1,076,738
-41% -$80M 0.57% 61
2016
Q3
$206M Sell
2,604,836
-577,821
-18% -$46.9M 1% 30
2016
Q2
$257M Buy
3,182,657
+130,817
+4% +$11.6M 1.33% 16
2016
Q1
$280M Buy
+3,051,840
New +$275M 1.52% 13

Other funds holding GILD

Ninety One (UK)'s GILD Position: Q2 2025 in Review

Ninety One (UK) sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 547,985 shares — an estimated $61.4M sold.

Ninety One (UK) first reported a position in GILD in Q1 2016 and held it in 13 quarters. The position peaked at $280M in Q1 2016. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Ninety One (UK) reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Ninety One (UK) sold 547,985 Gilead Sciences shares in Q2 2025, an estimated $61.4M.
  • Ninety One (UK) first reported a position in Gilead Sciences in Q1 2016 and held it in 13 quarters.
  • Ninety One (UK)'s Gilead Sciences position peaked at $280M in Q1 2016.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Ninety One (UK)'s 13F filing for Q2 2025, filed 18 Jul 2025.